Select Publications

Journal articles

Upham JW; Le Lievre C; Jackson DJ; Masoli M; Wechsler ME; Price DB; Mansur A; Detoraki A; Altraja A; James A; Nanzer-Kelly A; Côté A; Menzies-Gow A; Papaioannou A; Cheffins AM; Bourdin A; Mahboub B; Lipworth B; Celis-Preciado CA; Torres-Duque C; Bucca C; Porsbjerg C; Ulrik C; Corrigan C; Taube C; Farah C; Katelaris C; Langton D; Ryan D; Larenas-Linnemann D; Zervas E; Heffler E; Hoyte F; Puggioni F; Christoff G; Canonica GW; Carpagnano GE; Guida G; Katsoulotos G; Brusselle G; Rupani H; Jersmann H; Clifton I; Dhariwal J; Fingleton J; Duke J; Rimmer J; Douglass J; Fonseca J; van Boven J; Corless J; Harrington J; Maspero J; Miguel JL; Pipatvech K; Kenny K; Chapman K; Kostikas K; Lehtimäki L; Chung LP; Heaney L; Hang LW; Boulet LP; Perez-de-Llano L; Ricciardi L; Idrees M; Milanese M; Conte ME; Costantino MT; Siyue MK; Fitzgerald M; Hew M; Peters M; Tsai MJ; Patel M; Khan MH; Sadatsafavi M; Al-Ahmad M; Yacoub MR; De Gennaro M; Radhakrishna N; Hanania NA; Papadopoulos N; Lugogo N; Linaker N; Crimi N; Dennison P; Nair P; Mitchell PD; O'Byrne P; Pfeffer P; Kauppi P; Hughes P; Middleton P; Wark P; Bardin P; Fu PK; Akuthota P; Chaudhuri R; Campos R, 2021, 'Defining a Severe Asthma Super-Responder: Findings from a Delphi Process', Journal of Allergy and Clinical Immunology: In Practice, vol. 9, pp. 3997 - 4004, http://dx.doi.org/10.1016/j.jaip.2021.06.041

Thomas D; Harvey ES; McDonald VM; Stevens S; Upham JW; Katelaris CH; Kritikos V; Gillman A; Harrington J; Hew M; Bardin P; Peters M; Reynolds PN; Langton D; Baraket M; Bowden JJ; Bowler S; Chien J; Chung LP; Farah CS; Grainge C; Jenkins C; Katsoulotos GP; Lee J; Radhakrishna N; Reddel HK; Rimmer J; Sivakumaran P; Wark PAB; Gibson PG, 2021, 'Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry', Journal of Allergy and Clinical Immunology: In Practice, vol. 9, pp. 2715 - 2724.e5, http://dx.doi.org/10.1016/j.jaip.2021.01.028

Maltby S; McDonald VM; Upham JW; Bowler SD; Chung LP; Denton EJ; Fingleton J; Garrett J; Grainge CL; Hew M; James AL; Jenkins C; Katsoulotos G; King GG; Langton D; Marks GB; Menzies-Gow A; Niven RM; Peters M; Reddel HK; Thien F; Thomas PS; Wark PAB; Yap E; Gibson PG, 2021, 'Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetings', Internal Medicine Journal, vol. 51, pp. 169 - 180, http://dx.doi.org/10.1111/imj.14806

Harvey ES; Langton D; Katelaris C; Stevens S; Farah CS; Gillman A; Harrington J; Hew M; Kritikos V; Radhakrishna N; Bardin P; Peters M; Reynolds PN; Upham JW; Baraket M; Bowler S; Bowden J; Chien J; Chung LP; Grainge C; Jenkins C; Katsoulotos GP; Lee J; McDonald VM; Reddel HK; Rimmer J; Wark PAB; Gibson PG, 2020, 'Mepolizumab effectiveness and identification of super-responders in severe asthma', European Respiratory Journal, vol. 55, http://dx.doi.org/10.1183/13993003.02420-2019

McDonald VM; Hiles SA; Godbout K; Harvey ES; Marks GB; Hew M; Peters M; Bardin PG; Reynolds PN; Upham JW; Baraket M; Bhikoo Z; Bowden J; Brockway B; Chung LP; Cochrane B; Foxley G; Garrett J; Jayaram L; Jenkins C; Katelaris C; Katsoulotos G; Koh MS; Kritikos V; Lambert M; Langton D; Lara Rivero A; Middleton PG; Nanguzgambo A; Radhakrishna N; Reddel H; Rimmer J; Southcott AM; Sutherland M; Thien F; Wark PAB; Yang IA; Yap E; Gibson PG, 2019, 'Treatable traits can be identified in a severe asthma registry and predict future exacerbations', Respirology, vol. 24, pp. 37 - 47, http://dx.doi.org/10.1111/resp.13389

Hiles SA; Harvey ES; McDonald VM; Peters M; Bardin P; Reynolds PN; Upham JW; Baraket M; Bhikoo Z; Bowden J; Brockway B; Chung LP; Cochrane B; Foxley G; Garrett J; Hew M; Jayaram L; Jenkins C; Katelaris C; Katsoulotos G; Koh MS; Kritikos V; Lambert M; Langton D; Lara Rivero A; Marks GB; Middleton PG; Nanguzgambo A; Radhakrishna N; Reddel H; Rimmer J; Southcott AM; Sutherland M; Thien F; Wark PAB; Yang IA; Yap E; Gibson PG, 2018, 'Working while unwell: Workplace impairment in people with severe asthma', Clinical and Experimental Allergy, vol. 48, pp. 650 - 662, http://dx.doi.org/10.1111/cea.13153

Hew M; Gillman A; Sutherland M; Wark P; Bowden J; Guo M; Reddel HK; Jenkins C; Marks GB; Thien F; Rimmer J; Katsoulotos GP; Cook M; Yang I; Katelaris C; Bowler S; Langton D; Wright C; Bint M; Yozghatlian V; Burgess S; Sivakumaran P; Yan KY; Kritikos V; Peters M; Baraket M; Aminazad A; Robinson P; Jaffe A; Powell H; Upham JW; McDonald VM; Gibson PG, 2016, 'Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria', Clinical and Experimental Allergy, vol. 46, pp. 1407 - 1415, http://dx.doi.org/10.1111/cea.12774

Gibson PG; Reddel H; McDonald VM; Marks G; Jenkins C; Gillman A; Upham J; Sutherland M; Rimmer J; Thien F; Katsoulotos GP; Cook M; Yang I; Katelaris C; Bowler S; Langton D; Robinson P; Wright C; Yozghatlian V; Burgess S; Sivakumaran P; Jaffe A; Bowden J; Wark PAB; Yan KY; Kritikos V; Peters M; Hew M; Aminazad A; Bint M; Guo M, 2016, 'Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry', INTERNAL MEDICINE JOURNAL, vol. 46, pp. 1054 - 1062, http://dx.doi.org/10.1111/imj.13166

Katsoulotos G; Pappa G; Tarantili PA; Magoulas K, 2008, 'Preparation and characterization of functionalized low density polyethylene matrix biocomposites', Polymer Engineering and Science, vol. 48, pp. 902 - 911, http://dx.doi.org/10.1002/pen.21033

Katsoulotos G; Tarantili PA, 2008, 'The effect of matrix composition on the properties of cellulosic fibers-polyethylene composites', Journal of Applied Polymer Science, vol. 107, pp. 2385 - 2393, http://dx.doi.org/10.1002/app.27313

Stelzer-Braid S; Wong B; Robertson PW; Lynch GW; Laurie K; Shaw R; Barr I; Selleck P; Baleriola C; escott R; Katsoulotos GP; Rawlinson WD, 2008, 'A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies', Journal of Clinical Virology, vol. 43, pp. 241 - 243, http://dx.doi.org/10.1016/j.jcv.2008.06.012

Katsoulotos GP; Tanaka K; Molloy TJ; Stevens RL; Krilis S, 2007, 'Ras guanine nucleotide releasing protein 4 (RasGRP4) dependent pathways and genes that reversibly control the development, phenotype, and function of human mast cells (MCs)', Journal of Allergy and Clinical Immunology, vol. 119, pp. S50 - S50, http://dx.doi.org/10.1016/j.jaci.2006.11.217

Wong GW; Foster PS; Yasuda S; Qi JC; Mahalingam S; Mellor EA; Katsoulotos G; Li X; Boyce JA; Krilis SA; Stevens RL, 2002, 'Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase γ: TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor α/signal transducer and activator of transcription (STAT) 6-dependent pathway', Journal of Biological Chemistry, vol. 277, pp. 41906 - 41915, http://dx.doi.org/10.1074/jbc.M205868200


Back to profile page

ORCID as entered in ROS